Scholar Rock Holding Depreciation & Amortization Growth & History (SRRK)
Scholar Rock Holding's depreciation and amortization was $1.7M for fiscal 2025.
View full Scholar Rock Holding company overviewScholar Rock Holding annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.7M | −$279,000 | −14.40% |
| 2024 | 2024-12-31 | $1.9M | −$907,000 | −31.89% |
| 2023 | 2023-12-31 | $2.8M | −$142,000 | −4.76% |
| 2022 | 2022-12-31 | $3.0M | $359,000 | +13.67% |
| 2021 | 2021-12-31 | $2.6M | $1.1M | +76.19% |
| 2020 | 2020-12-31 | $1.5M | $188,000 | +14.43% |
| 2019 | 2019-12-31 | $1.3M | $496,000 | +61.46% |
| 2018 | 2018-12-31 | $807,000 | $138,000 | +20.63% |
| 2017 | 2017-12-31 | $669,000 | — | — |
Scholar Rock Holding quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $297,000 | −$120,000 | −28.78% |
| Q1 2026 | 2026-03-31 | $335,000 | −$58,000 | −14.76% |
| Q4 2025 | 2025-12-31 | $425,000 | — | — |
| Q3 2025 | 2025-09-30 | $423,000 | −$23,000 | −5.16% |
| Q2 2025 | 2025-06-30 | $417,000 | −$81,000 | −16.27% |
| Q1 2025 | 2025-03-31 | $393,000 | −$205,000 | −34.28% |
| Q3 2024 | 2024-09-30 | $446,000 | −$262,000 | −37.01% |
| Q2 2024 | 2024-06-30 | $498,000 | −$233,000 | −31.87% |
| Q1 2024 | 2024-03-31 | $598,000 | −$135,000 | −18.42% |
| Q3 2023 | 2023-09-30 | $708,000 | −$36,000 | −4.84% |
| Q2 2023 | 2023-06-30 | $731,000 | −$13,000 | −1.75% |
| Q1 2023 | 2023-03-31 | $733,000 | −$16,000 | −2.14% |
| Q3 2022 | 2022-09-30 | $744,000 | $71,000 | +10.55% |
| Q2 2022 | 2022-06-30 | $744,000 | $107,000 | +16.80% |
| Q1 2022 | 2022-03-31 | $749,000 | $159,000 | +26.95% |
| Q3 2021 | 2021-09-30 | $673,000 | $285,000 | +73.45% |
| Q2 2021 | 2021-06-30 | $637,000 | $244,000 | +62.09% |
| Q1 2021 | 2021-03-31 | $590,000 | $199,000 | +50.90% |
| Q3 2020 | 2020-09-30 | $388,000 | $57,000 | +17.22% |
| Q2 2020 | 2020-06-30 | $393,000 | $78,000 | +24.76% |
| Q1 2020 | 2020-03-31 | $391,000 | $120,000 | +44.28% |
| Q3 2019 | 2019-09-30 | $331,000 | $123,000 | +59.13% |
| Q2 2019 | 2019-06-30 | $315,000 | $135,000 | +75.00% |
| Q1 2019 | 2019-03-31 | $271,000 | $92,000 | +51.40% |
| Q3 2018 | 2018-09-30 | $208,000 | $41,000 | +24.55% |
| Q2 2018 | 2018-06-30 | $180,000 | — | — |
| Q1 2018 | 2018-03-31 | $179,000 | — | — |
| Q3 2017 | 2017-09-30 | $167,000 | — | — |
Scholar Rock Holding depreciation and amortization trends
Over the last five fiscal years, Scholar Rock Holding's depreciation and amortization increased from $1.5M to $1.7M, a change of $167,000. The latest reported quarter, Q2 2026, shows $297,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scholar Rock Holding source filings ↗Community posts
Scholar Rock wins FDA approval for muscle-targeted SMA treatment
Scholar Rock ($SRRK) received FDA approval for ISEMBYLD, its apitegromab treatment for spinal muscular atrophy, in patients aged two and older receiving SMN2-targeted therapy. The company plans to begin shipping the medicine within days. Th ...